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Introduction
Paget’s disease of the nipple is a rare form (1-4%) 
of breast cancer. Clinically it manifests most com-
monly as an eczematous or erythematous lesion of 
the nipple. In Paget’s disease of the nipple, Paget 
cells, which are malignant glandular cells, are seen 
within the epidermis of the nipple and sometimes ex-
tend to the areola or adjacent skin. It is usually asso-
ciated with an underlying carcinoma, which is in this 
case a postulated source of Paget cells [1-3]. In rare 
cases not associated with the underlying carcinoma, 
the Paget cells might presumably derive from Toker 
cells [2, 4] or malignant transformation of keratino-
cytes [5].
Pigmented Paget’s disease of the nipple (PPD) is 
a very rare variant of Paget’s disease of the nipple 
[1, 4, 6]. Available reports describe 24 cases of PPD 
[1, 4]. It manifests clinically as a pigmented lesion of 
the nipple, which is caused by accumulation of mel-
anin [1, 4, 6]. Hyperpigmentation is associated with 
proliferation of dendritic melanocytes or with accu-
mulation of melanin within the cytoplasm of Paget 
cells, keratinocytes or melanophages [7, 8].
Case report
A 60-year-old woman was admitted to the 1st 
Chair of General, Oncological, and Gastrointestinal 
Surgery, Jagiellonian University Medical College be-
cause of the diagnosis of an invasive ductal carcinoma 
of her left breast. At physical examination no palpa-
ble tumor in the breast or enlarged regional lymph 
nodes were revealed, but the nipple was inverted and 
surrounded by a pigmented area of skin. According 
to the patient’s statements, the nipple had been in-
verted for the last five years. No contributory fam-
ily history was revealed. The patient suffered from 
hypertension, sciatica and chronic pancreatitis. She 
had experienced a cerebral stroke and had undergone 
C-section, appendectomy and cholecystectomy.
Mammography showed a tumor of the left breast, 
sized 15 mm, surrounded by areas of microcalcifica-
tions up to 110 mm in the largest dimension. Ultra-
sonography of the left breast showed an invasive le-
sion, sized 14 × 11 × 8 mm, surrounded by an area 
of swelling, spreading towards the skin and nipple. 
Ultrasonography of the left axilla revealed a lymph 
node suspicious for metastatic disease, but the cyto-
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logical examination was negative for atypical cells. 
Because of the extent of mammographically detected 
lesions the patient was qualified for simple mastecto-
my with sentinel lymph node biopsy.
Macroscopically there was an invasive tumor in the 
internal upper quadrant, sized 1.4 × 1.2 × 0.9 cm, 
which was removed with a margin of the surrounding 
tissues. The nipple was inverted and surrounded by 
a pigmented area, irregular in contour and pigmenta-
tion, diameter 2 cm. There were also two warts, sized 
1.2 cm and 0.3 cm, noticeable on the skin’s surface.
Histological examination of the macroscopical-
ly visible tumor showed an invasive carcinoma of no 
special type, grade 3, 14 mm in the largest dimension, 
with vascular invasion adjacent to the tumor. Ductal 
carcinoma in situ, intermediate grade, solid pattern, 
with central necrosis, identified within the tumor, 
involved no more than 10% of the area of invasive 
cancer. It also involved ducts and acini in the vicinity 
of the tumor (Fig. 1). Two skin warts turned out to 
be seborrheic warts. Immunohistochemistry revealed 
that invasive carcinoma cells were positive for estro-
gen and progesterone receptors (70% and 40% of 
cells showing strong nuclear expression, respectively) 
and positive for HER2 (score 3+). According to the 
2013 St Gallen consensus, the tumor type was lumi-
nal B (HER-2 positive). Two sentinel lymph nodes 
were free of metastases, so the disease stage was IA.
At all levels of the epidermis of the nipple, both 
single cells and cells forming nests were visible. These 
cells showed abundant pale cytoplasm, and some 
of them contained melanin. Melanin was also seen 
within the cytoplasm of keratinocytes, melanocytes 
and in the skin melanophages (Figs. 2, 3). Immuno-
histochemical studies demonstrated that the tumor 
cells were positive for keratin 7 (Fig. 4), epithelial 
membrane antigen, gross cystic disease protein 15, 
estrogen and progesterone receptors as well as HER2 
(Figs. 5, 6). These cells were negative for melanocyt-
ic antigens (HMB45 and melanA), but these stains 
demonstrated numerous dendritic melanocytes ac-
companying the tumor cells (Figs. 7, 8). Altogeth-
er these findings were consistent with a diagnosis of 
pigmented Paget’s disease of the nipple.
After the operation the patient received chemo-
therapy: 3 cycles of epirubicin, 5-fluorouracil and 
cyclophosphamide, and then 3 cycles of docetaxel. 
Currently the patient is receiving trastuzumab and 
hormonal therapy (an aromatase inhibitor) with fairly 
good tolerance of treatment.
Discussion
Pigmented Paget’s disease of the nipple is an ex-
tremely uncommon variant of mammary Paget’s dis-
ease that can mimic malignant melanoma on clinical, 
dermatological and even histopathological presenta-
tion [1, 4, 6]. It is not uncommon to find melanin in 
Paget cells’ cytoplasm. Culberson and Horn reported 
presence of pigment within Paget cells’ cytoplasm in 
10 of 25 cases (40%), but the degree of pigmenta-
tion varied, being particularly heavy in only one case 
[9], which is probably the first reported case of PPD. 
Neubecker and Bradshaw observed melanin in 8 of 
13 cases of Paget’s disease. In the majority of these 
cases pigment granules were few in number and pres-
ent only in isolated cells. Similarly to the previous-
ly mentioned report, in only one case did numerous 
cells contain abundant pigment [10]. Only in these 
heavily pigmented cases does clinically visible pig-
mentation warrant classification as PPD [4].
The mechanism of hyperpigmentation in PPD 
still remains unknown. There are several hypothe-
ses trying to explain its origin. The first one involves 
stimulation of melanocytes by growth factors that are 
produced by cancer cells [1, 7, 11, 12]. The areola, as 
Fig. 1. Invasive carcinoma with accompanying ductal car-
cinoma in situ of the left breast. HE, objective magnifica-
tion 10×
Fig. 2. Paget cells, single and forming nests, are seen at all 
levels of the epidermis. Within the dermis some melano-
phages can be seen. HE, objective magnification 20×
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Fig. 3. Melanin is seen within Paget cells’ and keratino-
cytes’ cytoplasm. HE, objective magnification 40×
Fig. 4. CK7 demonstrates numerous Paget cells within the 
epidermis. CK7, objective magnification 40×
Fig. 5. HER2 expression in Paget cells. HER2, objective 
magnification 20×
Fig. 6. Estrogen receptor expression in Paget cells. ER, ob-
jective magnification 40×
Fig. 7. Numerous dendritic melanocytes accompanying 
the tumor cells showing expression of HMB45. HMB45, 
objective magnification 40×
Fig. 8. Numerous dendritic melanocytes accompanying 
the tumor cells showing expression of melanA. MelanA, 
objective magnification 40×
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a region rich in melanocytes, shows visible effects of 
that stimulation. However, similar lesions were also 
observed in extramammary epidermotropic metasta-
ses of breast carcinoma [7] and even in other types 
of carcinomas [7, 13-16]. Some authors suggest that 
the hyperpigmentation may be caused by pigment 
blockage of melanocytes that have been stimulated to 
grow and, after that, chemoattracted by cancer cells. 
During migration they are blocked and transfer mel-
anin to other epithelial cells [7, 17]. Other authors 
suggest that the epithelial cells of cancer phagocytose 
melanin from the melanocytes, which causes hyper-
pigmentation [1, 7, 11, 18].
Differential diagnosis of this rare entity might be 
challenging and mainly includes pigmented epider-
motropic metastases of breast carcinoma and malig-
nant melanoma [7]. Epidermotropic metastases of 
breast carcinoma might rarely be pigmented [15]. 
The differential diagnosis is usually based on clinical 
history [1, 15]. Epidermotropic metastases of breast 
carcinoma usually occur on the mammary skin, mas-
tectomy scar or anterior chest wall in a patient with 
a known history of mammary carcinoma. In contrast, 
PPD is usually the first manifestation of the disease 
and affects the nipple [1]. Histological assessment 
might assist in differential diagnosis, as in epidermo-
tropic metastases of breast carcinoma neoplastic cells 
involve not only the epidermis but also the dermis 
[15]. Malignant melanoma only rarely affects the 
nipple. In melanoma in situ single cells or cells in 
nests are seen along the dermoepidermal junction and 
scattered at all levels of the epidermis. In contrast, 
Paget cells are scattered through suprabasal layers of 
the epidermis [1, 7, 15]. In our case this feature was 
not helpful, as we observed Paget cells at all levels of 
the epidermis, including the dermoepidermal junc-
tion. More promising in differential diagnosis seems 
to be the use of immunohistochemistry. Melanoma 
cells (in both melanoma in situ and epidermotropic 
metastatic melanoma) usually demonstrate strong 
expression of S100 protein and typical melanocytic 
markers such as HMB45, melanA and MiTF, whilst 
Paget cells are usually negative for these markers. In 
contrast, melanoma cells usually do not express cyto-
keratins, EMA or CEA, which are usually expressed 
by Paget cells [1, 7]. However, some authors report 
S100 or HMB45 positivity in Paget cells. Neverthe-
less, the expression of epithelial markers by the same 
cells usually resolves the problem and favors the diag-
nosis of PPD [1, 7, 19]. Additional support in diag-
nosis of PPD might be the expression by these cells of 
estrogen and progesterone receptors [1, 3], although 
reported positivity for estrogen and progesterone re-
ceptors in Paget’s disease varies and does not exceed 
44% of cases [3]. Instead, HER2 positivity is a more 
consistent finding and might help in differential di-
agnosis [1, 3]. Nevertheless, caution in interpretation 
of immunohistochemical stains and use of a panel of 
markers is recommended due to the numerous me-
lanocytes in PPD showing expression of melanocytic 
antigens, which might be misleading.
In summary, pigmented mammary Paget’s disease 
is a rare variant of Paget’s disease. However, it should 
not be forgotten and ought to be taken into account 
in the differential diagnosis of pigmented lesion of 
the nipple.
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